Login / Signup

Cardiogenic Shock Intravascular Cooling Trial (CHILL-SHOCK).

Nikhil GuptaRohan J KalathiyaNikhil SinghNadeem BandealyMaryam NeyestanakStephanie BesserCynthia ArevaloJanet FriantJohn E A BlairSandeep NathanAtman P ShahJonathan Paul
Published in: Journal of cardiac failure (2024)
TTC may be a safe adjunct therapy for patients presenting with CS and may yield improvement in specific hemodynamic parameters.
Keyphrases
  • phase iii
  • study protocol
  • phase ii
  • clinical trial
  • coronary artery
  • randomized controlled trial
  • open label
  • double blind